Dive Into Microbes, Metals and Metabolites for Drug Discovery

RECORD | Already taken place Th, 21.9.2023

Latest research into deriving natural products from the marine invertebrate Botryllus schlosseri.

Technology Networks: Dive Into Microbes, Metals and Metabolites for Drug Discovery

Host-associated microbial communities are unique sources for natural product drug discovery.

By studying these microbes, novel and targeted drug leads can be identified and critical questions answered within the broader field of chemical ecology.

Dr. Balunas’ research connects the dots between microbes, metals and metabolites to discover new medicines for a wide range of human diseases.

In this webinar, Dr. Balunas will showcase her latest research into deriving natural products from the marine invertebrate Botryllus schlosseri.

Attend this webinar to discover:

Marine natural product drug discovery
Advanced informatics tools for metabolomics
Untargeted metabolomics with timsTOF

Presenter: Dr. Marcy Balunas (Associate Professor, University of Michigan)

Technology Networks

Dive Into Microbes, Metals and Metabolites for Drug Discovery

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector